Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lincoln Nadauld

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Future Oncology (London, England)|September 5, 2022
Considerations in the implementation of multicancer early detection testsLincoln Nadauld, Dana P Goldman
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Translational Medicine (Sunnyvale, Calif.)|May 18, 2013
Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin Embedded Tumors with Droplet Digital PCRLincoln Nadauld, John F Regan, Laura Miotke, et al.
Cancers|November 27, 2021
Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare CostsAdrienne T Perkins, Derrick Haslem, Jessica Goldsberry, et al.
Lancet (London, England)|October 7, 2023
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyDeb Schrag, Tomasz M Beer, Charles H McDonnell, et al.
The Lancet. Oncology|January 16, 2025
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln Nadauld, Charles H McDonnell, Christina A Dilaveri, et al.
NPJ Precision Oncology|April 6, 2025
The single-cell spatial landscape of stage III colorectal cancersAndrew Su, HoJoon Lee, Minh Tran, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
The single-cell spatial landscape of stage III colorectal cancersAndrew Su, HoJoon Lee, Minh Tran, et al.
Nature Medicine|May 27, 2014
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid cultureXingnan Li, Lincoln Nadauld, Akifumi Ootani, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|September 5, 2022
Considerations in the implementation of multicancer early detection testsLincoln Nadauld, Dana P Goldman
Pharmacoeconomics - Open|January 8, 2024
Health State Utilities Associated with False-Positive Cancer Screening ResultsLouis S Matza, Timothy A Howell, Eric T Fung, et al.
Translational Medicine (Sunnyvale, Calif.)|May 18, 2013
Quantitative and Sensitive Detection of Cancer Genome Amplifications from Formalin Fixed Paraffin Embedded Tumors with Droplet Digital PCRLincoln Nadauld, John F Regan, Laura Miotke, et al.
Cancers|November 27, 2021
Universal Germline Testing of Unselected Cancer Patients Detects Pathogenic Variants Missed by Standard Guidelines without Increasing Healthcare CostsAdrienne T Perkins, Derrick Haslem, Jessica Goldsberry, et al.
Lancet (London, England)|October 7, 2023
Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort studyDeb Schrag, Tomasz M Beer, Charles H McDonnell, et al.
The Lancet. Oncology|January 16, 2025
Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln Nadauld, Charles H McDonnell, Christina A Dilaveri, et al.
NPJ Precision Oncology|April 6, 2025
The single-cell spatial landscape of stage III colorectal cancersAndrew Su, HoJoon Lee, Minh Tran, et al.
JCO Precision Oncology|February 1, 2022
Tissue/Site-Agnostic Study of Ribociclib for Tumors With Cyclin D-CDK4/6 Pathway Genomic Alterations: A Phase II, Open-Label, Single-Arm Basket StudyJulio Peguero, Davendra P S Sohal, Bert H O'Neil, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
The single-cell spatial landscape of stage III colorectal cancersAndrew Su, HoJoon Lee, Minh Tran, et al.
Nature Medicine|May 27, 2014
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid cultureXingnan Li, Lincoln Nadauld, Akifumi Ootani, et al.
Pageof 2